![]() | Up a level |
Naimi, Adel and Mohammed, Rebar N. and Raji, Ahmed and Chupradit, Supat and Valerievich Yumashev, Alexei and Suksatan, Wanich and Shalaby, Mohammed Nader and Thangavelu, Lakshmi and Kamrava, Siavash and Shomali, Navid and Sohrabi, Armin D. and Adili, Ali and Noroozi-Aghideh, Ali and Razeghian, Ehsan (2022) Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons. Cell communication and signaling.